The University of Oxford has launched the first study to assess the safety and immune responses in children and young adults of its coronavirus vaccine. The university said that previous trials of......
Human trials of an eagerly-awaited vaccine, developed by the prestigious Oxford University, against the novel coronavirus began in the UK on Thursday, with scientists giving it an 80 per cent......
The issue of administering 'additional' dose of COVID-19 vaccine to immunocompromised individuals will be deliberated upon in the meeting of the National Technical Advisory Group on Immunisation......
The current wave of the coronavirus pandemic in Delhi is being fuelled by the United Kingdom variant as its prevalence in genomes sequenced in the national capital nearly doubled to 50 per cent......
The coronavirus vaccine developed by teams at the University of Oxford has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age. The findings......
As campaigns against Chinese brands intensify and the virus keeps people indoors, Vivo plays it slow with a digital-first launch plan. In the ordinary scheme of things, the launch of V19, the......